Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 353

1.

In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine.

Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Kolodzie K, Schulte Am Esch J.

Anesthesiology. 2003 Apr;98(4):944-9.

PMID:
12657857
2.

Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.

Fiege M, Wappler F, Scholz J, Weisshorn R, von Richthofen V, Schulte am Esch J.

J Clin Anesth. 2000 Mar;12(2):123-8.

PMID:
10818326
3.

Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.

Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Kolodzie K, Schulte am Esch J.

Eur J Anaesthesiol. 2005 Apr;22(4):283-8.

PMID:
15892406
4.

[Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].

Fiege M, Wappler F, Scholz J, von Richthofen V, Brinken B, Schulte am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Sep;33(9):557-63. German.

PMID:
9787864
5.

4-chloro-m-cresol is a trigger of malignant hyperthermia in susceptible swine.

Wappler F, Scholz J, Fiege M, Kolodzie K, Kudlik C, Weisshorn R, Schulte am Esch J.

Anesthesiology. 1999 Jun;90(6):1733-40.

PMID:
10360873
6.

[4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].

Wappler F, Scholz J, von Richthofen V, Fiege M, Steinfath M, Schulte am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1997 Sep;32(9):541-8. German.

PMID:
9417254
7.

[Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].

Gerbershagen MU, Fiege M, Weisshorn R, Kolodzie K, Wappler F.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Mar;39(3):147-52. German.

PMID:
15042504
8.

Effects of theophylline on anesthetized malignant hyperthermia-susceptible pigs.

Fiege M, Weisshorn R, Kolodzie K, Wappler F, Gerbershagen MU.

J Biomed Biotechnol. 2011;2011:937479. doi: 10.1155/2011/937479. Epub 2011 Oct 26.

9.

Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").

Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J.

Anesthesiology. 2003 Nov;99(5):1132-6.

PMID:
14576550
10.

[Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].

Gerbershagen MU, Wappler F, Fiege M, Weisshorn R, Kolodzie K, Schulte am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Feb;39(2):81-6. German.

PMID:
14767797
11.

[In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].

Weisshorn R, Wappler F, Fiege M, Gerbershagen M, Schulte Am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2002 Mar;37(3):138-43. German.

PMID:
11889614
12.

Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.

Hartung E, Koob M, Anetseder M, Schoemig P, Krauspe R, Hogrefe G, Engelhardt W.

Acta Anaesthesiol Scand. 1996 Apr;40(4):437-44.

PMID:
8738688
13.

In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.

Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Schulte am Esch J.

Anesth Analg. 1996 Jun;82(6):1230-6.

PMID:
8638796
15.
16.

Histomorphologic examination of skeletal muscle preparations does not differentiate between malignant hyperthermia-susceptible and -normal patients.

von Breunig F, Wappler F, Hagel C, von Richthofen V, Fiege M, Weisshorn R, Stavrou D, Schulte am Esch J.

Anesthesiology. 2004 Apr;100(4):789-94.

PMID:
15087612
17.

Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.

Weisshorn R, Wappler F, Fiege M, Gerbershagen MU, Kolodzie K, Alberts P, Horn EP, Schulte Am Esch J.

J Clin Anesth. 2004 Aug;16(5):353-7.

PMID:
15374556
18.

5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.

Wappler F, Scholz J, Fiege M, Richter A, Steinfath M, Weisshorn R, Schulte am Esch J.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Oct;360(4):376-81.

PMID:
10551274
19.

Abnormal action potential responses to halothane in heart muscle isolated from malignant hyperthermia-susceptible pigs.

Roewer N, Greim C, Rumberger E, Schulte am Esch J.

Anesthesiology. 1995 Apr;82(4):947-53.

PMID:
7717567
20.

In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swine.

Gerbershagen MU, Wappler F, Fiege M, Weilsshorn R, Alberts PA, von Breunig F, Schulte am Esch J.

Eur J Anaesthesiol. 2002 Feb;19(2):135-40.

PMID:
11999597

Supplemental Content

Support Center